Tetracaine Compared to Placebo for Reducing Pain With Palivizumab - A Pilot Study

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a small study known as a pilot study. This pilot study is being done to see if a difference in pain from intramuscular palivizumab injection can be detected if tetracaine a topical numbing gel is used compared to no medication (placebo). If a difference is found in this pilot study, then a larger study may be done to confirm that there is a difference in pain experience.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Fraser Health
• Treatments: Palivizumab; Tetracaine

Criteria

Inclusion Criteria:

• Infants between 1 month and 2 years of age receiving palivizumab at Surrey Memorial Hospital for 2 consecutive intramuscular injections during the 2007/8 season

• Parents need to complete informed consent.

Exclusion Criteria:

• Allergy/sensitivity to tetracaine, or ester type anaesthetics.

• Infants who present with fever or illness that prevent administration of palivizumab.